OOIR: Observatory of International Research

Papers

(The H4-Index of Biotechnology Letters is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Influence of affinity tags and tobacco PR1a signal peptide on detection, purification and bioactivity analyses of the small oomycete apoplastic effectors	53
Listeria monocytogenes is a solvent tolerant organism secreting a solvent stable lipase: potential biotechnological applications	52
Recombinant expression, downstream optimization, and therapeutic evaluation of recombinant human interleukin-37 for cancer therapy	37
Cell density detection based on a microfluidic chip with two electrode pairs	30
Affinity chromatography studies for Mespilus germanica L. polyphenol oxidase	27
Activation of galactose utilization by the addition of glucose for the fermentation of agar hydrolysate using Lactobacillus brevis ATCC 14869	25
The pedal-like loop of (R)-selective transaminases plays a critical role to the functionality of the enzyme	22
Unraveling the molecular mechanisms of selenite reduction: transcriptomic analysis of Bacillus reveals the key role of sulfur assimilation	19
Antisense oligonucleotides: targeting oncogenic long non-coding RNAs for cancer therapy	17
Silica nanoparticles enhance interfacial self-adherence of a multi-layered extracellular matrix scaffold for vascular tissue regeneration	17
Effects of three light–dark cycles on circadian rhythm-related genes and photosynthetic parameters in carrot	16
Directed evolution of cholesterol oxidase with improved thermostability using error-prone PCR	16
Synthesis of β-ionone from xylose and lignocellulosic hydrolysate in genetically engineered oleaginous yeast Yarrowia lipolytica	16
High throughput screening and metabolic engineering of Saccharopolyspora spinosa for spinosad production	15
Design and application of expression constructs for FMDV serotype O structural proteins	15